Science

AddToAny

Google+ Facebook Twitter Twitter

Blurring boundaries: Ethics and artificial intelligence

With artificial intelligence becoming ever more prominent in biomedical labs and research, biomedical scientist turned ethicist Sarah E Carter looks at the pressing issues.

Artificial intelligence (AI) is increasingly prevalent in all aspects of life, including the biomedical scientist’s laboratory. While a universal definition of AI is still a matter of debate, the Institute of Electrical and Electronics Engineers in the US broadly defines AI as: “The theory and development of computer systems that are able to perform tasks which normally require human intelligence such as, visual perception, speech recognition, learning, decision-making, and natural language processing.”

In the lab, we now see examples of these intelligent computer systems tackling research tasks, such as tissue imaging and data visualisation. They have also pushed the boundaries of what was possible in biomedical research through their ability to model data on a massive scale, allowing researchers to utilise new tools, such as in silico drug development models. As AI use in the lab becomes more pervasive, an increasing number of research groups now employ a data specialist, and more and more computer science courses are requirements of biomedical graduate programmes. It’s clear that the future of biomedical research will be fuelled by data, AI, and computing power.

Please click here to read the full article.

Image Credit | Getty

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top